Recommended Dosing of Telmisartan for Adults with Hypertension
The usual starting dose of telmisartan for adults with hypertension is 40 mg once daily, with a target dose of 80 mg once daily for optimal blood pressure control. 1, 2
Dosing Guidelines
- The initial dose of telmisartan is typically 40 mg once daily, with most of the antihypertensive effect becoming apparent within 2 weeks and maximal reduction generally attained after 4 weeks 2
- Blood pressure response is dose-related over the range of 20 to 80 mg, with 40-80 mg/day considered the maximum effective dosage range 2, 3
- For patients with stage 1 hypertension and 10-year ASCVD risk ≥10%, initiation with telmisartan as a single antihypertensive drug is reasonable 1
- For patients with stage 2 hypertension (BP ≥140/90 mmHg with BP more than 20/10 mmHg above target), initiation with combination therapy including telmisartan is recommended 1, 4
Special Population Considerations
- No initial dosage adjustment is necessary for elderly patients or patients with renal impairment, including those on hemodialysis 2
- Patients on dialysis may develop orthostatic hypotension and should have their blood pressure closely monitored 2
- Telmisartan can be administered with or without food 2
Monitoring and Follow-up
- Blood pressure should be monitored regularly during dose titration 4
- Follow-up evaluation of adherence and response to treatment should occur at monthly intervals until control is achieved 4
- Monitor for hyperkalemia, especially in patients with chronic kidney disease or those on potassium supplements or potassium-sparing drugs 1
Treatment Algorithm
Initial therapy:
Dose titration:
Combination therapy:
Important Precautions
- Telmisartan is contraindicated in patients with known hypersensitivity to the drug 2
- Do not co-administer aliskiren with telmisartan in patients with diabetes 2
- The American College of Cardiology advises against combining telmisartan with ACE inhibitors or other ARBs, as this combination is potentially harmful 1
- In patients with an activated renin-angiotensin system (e.g., volume- or salt-depleted patients), symptomatic hypotension may occur after initiation of therapy 2
- Telmisartan is contraindicated during pregnancy, especially in the second and third trimesters 2
Clinical Efficacy
- At doses of ≥40 mg, telmisartan produces statistically significant reductions in blood pressure 3
- Telmisartan 40 to 80 mg/day has shown similar efficacy to amlodipine 5 to 10 mg/day, atenolol 50 to 100 mg/day, and ACE inhibitors like enalapril 5 to 20 mg/day 7
- Long-term studies have demonstrated that telmisartan maintains its efficacy over extended treatment periods of up to 4 years 6